Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2026-02-27 @ 6:49 AM
Study NCT ID:
NCT02659020
Status:
COMPLETED
Last Update Posted:
2022-05-09
First Post:
2016-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-27
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-15
First Submit QC Date:
None
Study First Post Date:
2016-01-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-07-26
Results First Submit QC Date:
None
Results First Post Date:
2021-10-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-15
Last Update Post Date:
2022-05-09
Last Update Post Date Type:
ACTUAL